Back to Search
TAI LAI LI, MD
MD
Family Medicine Physician
NPI: 1063114197Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC).
PMID 19524318·Lung Cancer·2010
3-trial
Skin toxicities associated with epidermal growth factor receptor inhibitors.
PMID 19452131·Target Oncol·2009
6-review
Development of a miniaturized piezoelectric ultrasonic transducer.
PMID 19411223·IEEE Trans Ultrason Ferroelectr Freq Control·2009
8-other
[Regulation effect of calcium and salicylic acid on defense enzyme activities in tomato leaves under sub-high temperature stress].
PMID 19637596·Ying Yong Sheng Tai Xue Bao·2009
8-other
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.
PMID 19153124·Ann Oncol·2009
3-trial
Insights into networks of functional microbes catalysing methanization of cellulose under mesophilic conditions.
PMID 19128320·Environ Microbiol·2009
8-other
Simultaneous analysis of microbial identity and function using NanoSIMS.
PMID 18028417·Environ Microbiol·2008
8-other
Biodegradation of organonitriles by adapted activated sludge consortium with acetonitrile-degrading microorganisms.
PMID 17544472·Water Res·2007
8-other
Role of the pineal gland in ocular development of the chick in normal and constant light conditions.
PMID 17065535·Invest Ophthalmol Vis Sci·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2068 E 14th St Fl 1
Brooklyn, NY 11229 - Phone
- (719) 339-1987
Quick Facts
- NPI
- 1063114197
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile